Related Experiment Video

Updated: Oct 8, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Interferon-alpha inhibits cyclooxygenase-1 and stimulates cyclooxygenase-2 expression in bladder cancer cells in

P J Boström1, P Uotila, P Rajala

  • 1Department of Surgery, Turku University Central Hospital, Turku, Finland.

Urological Research
|April 20, 2001
PubMed

Insights

Interferon-alpha (IFN-alpha) alters cyclooxygenase (Cox) enzyme expression in bladder cancer cells. While IFN-alpha inhibits Cox-1, it upregulates Cox-2, potentially impacting cancer treatment outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Cyclooxygenase enzymes (Cox-1 and Cox-2) are key in prostaglandin synthesis, influencing inflammation, immune responses, and cancer.
  • Cyclooxygenase-2 (Cox-2) is often upregulated in cancers, potentially promoting tumor growth and angiogenesis.
  • Interferon-alpha (IFN-alpha) is a treatment for bladder cancer, but its precise molecular effects, particularly on Cox enzymes, require further elucidation.

Purpose of the Study:

  • To investigate the impact of human recombinant IFN-alpha on the expression of Cox-1 and Cox-2 in two human bladder cancer cell lines (5637 and T24).
  • To understand how different concentrations of IFN-alpha affect the mRNA levels of Cox-1 and Cox-2 in these cell lines.

Main Methods:

  • Cultured human bladder cancer cell lines (5637 and T24) were treated with varying concentrations of human recombinant IFN-alpha (100, 1,000, and 10,000 U/ml).
  • Messenger RNA (mRNA) expression levels of Cox-1 and Cox-2 were analyzed under basal conditions and after IFN-alpha treatment.

Main Results:

  • Both Cox-1 and Cox-2 mRNA were expressed in 5637 and T24 cells.
  • Cox-1 expression was lower in 5637 cells and higher in T24 cells; IFN-alpha significantly decreased Cox-1 expression in both cell lines at the highest concentration.
  • Cox-2 expression was prominent in 5637 cells and low in T24 cells; IFN-alpha treatment led to increased Cox-2 expression in both cell lines, with varying dose-dependency.

Conclusions:

  • IFN-alpha differentially regulates Cox-1 and Cox-2 expression in bladder cancer cells.
  • The observed upregulation of Cox-2 by IFN-alpha may have implications for the efficacy of IFN-alpha therapy, potentially by suppressing the cell-mediated immune response.
  • The inhibition of Cox-1 by IFN-alpha could be a beneficial effect, given Cox-1's role in promoting angiogenesis.

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...